Fig. 1

Evaluation of clinical parameters in patients with mild to moderate asthma. Changes in Type 2 inflammatory markers (A),asthma control indicators (B),and sinusitis treatment Indicators (C) at 3 months and 1 year after dupilumab administration are shown in A. Pre and 3 month: n = 50, 1 year: n = 18. Each panel shown represents the mean ± SD. *p < 0.05,**p < 0.01 by student’s t test